Nivolumab 40 mg in 4 ml Injection Clinical Trials
2 recruitingDrug
Phase 31Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Uterine Cervical Neoplasms
Hospital Israelita Albert Einstein112 enrolled14 locationsNCT05492123
Recruiting
Phase 3
Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL
Primary Mediastinal Lymphoma
National Research Center for Hematology, Russia100 enrolled1 locationNCT06188676